| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/02/2002 | EP1201239A1 Cyclic amine ccr3 antagonists |
| 05/02/2002 | EP1201238A1 Sulfonamide derivatives and remedies for allodynia |
| 05/02/2002 | EP1201237A1 Composition comprising an amide or a dialkylsulphoxide derivative for the treatment of cancer |
| 05/02/2002 | EP1201236A1 Medicinal compositions for preventing or treating viral myocarditis |
| 05/02/2002 | EP1201235A1 Neuropathy improvers containing nitrogenous compounds as the active ingredient |
| 05/02/2002 | EP1201234A2 Treatment of diseases with adamantane derivates |
| 05/02/2002 | EP1201233A1 Transdermal dosage form |
| 05/02/2002 | EP1201231A2 Suspension or particle-solvent mixture system of zinc-containing calcium phosphate microparticle, and therapeutic agent for treating zinc deficiency |
| 05/02/2002 | EP1201230A2 Solution-based transdermal drug delivery system comprising a vasodilator |
| 05/02/2002 | EP1201227A2 Use of flavonoids as immunomodulating or immunoprotecting agents in cosmetic and dermatological compositions |
| 05/02/2002 | EP1201125A1 Antiseptic/antifungal agent and endermic liniment composition which contains it |
| 05/02/2002 | EP1200616A2 Enhanced delivery via serpin enzyme complex receptor ligands |
| 05/02/2002 | EP1200607A2 Tet repressor-based transcriptional regulatory proteins |
| 05/02/2002 | EP1200602A1 Dsp-11 dual-specificity map kinase phophatase |
| 05/02/2002 | EP1200596A2 Human synthetases |
| 05/02/2002 | EP1200595A2 Myxoma virus genes for immune modulation |
| 05/02/2002 | EP1200591A1 Human homologue of bovine neuroendocrine secretory protein, nesp55, polynucleotides and uses thereof linked with obesity |
| 05/02/2002 | EP1200590A1 C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof |
| 05/02/2002 | EP1200585A1 T-cell receptor gamma alternate reading frame protein, (tarp) and uses thereof |
| 05/02/2002 | EP1200582A2 Human proteins having hydrophobic domains and dnas encoding these proteins |
| 05/02/2002 | EP1200580A2 MODULATION OF OLIGONUCLEOTIDE CpG-MEDIATED IMMUNE STIMULATION BY POSITIONAL MODIFICATION OF NUCLEOSIDES |
| 05/02/2002 | EP1200579A2 Antisense therapy for hormone-regulated tumors |
| 05/02/2002 | EP1200573A1 Antisense modulation of mekk1 expression |
| 05/02/2002 | EP1200572A1 Antisense modulation of liver glycogen phosphorylase expression |
| 05/02/2002 | EP1200570A1 Antisense modulation of p13 kinase p110 delta expression |
| 05/02/2002 | EP1200560A1 Melanin-concentrating hormone receptor |
| 05/02/2002 | EP1200481A1 A biodegradable polycation composition for delivery of an anionic macromolecule |
| 05/02/2002 | EP1200479A1 Multiple cytokine-antibody complexes |
| 05/02/2002 | EP1200463A2 Antimicrobial histone h1 compositions, kits, and methods of use thereof |
| 05/02/2002 | EP1200456A1 Antisense modulation of pten expression |
| 05/02/2002 | EP1200455A1 Enzyme catalyzed therapeutic activation |
| 05/02/2002 | EP1200451A1 Radiolabelled bisphosphonates and method |
| 05/02/2002 | EP1200447A1 Oxazinocarbazoles for the treatment of cns diseases |
| 05/02/2002 | EP1200446A1 OXATHIEPINO 6,5- i b /i ]DIHYDROPYRIDINES, AND RELATED COMPOSITIONS AND METHODS |
| 05/02/2002 | EP1200445A1 Thienopyranecarboxamide derivatives |
| 05/02/2002 | EP1200444A1 Novel xanthone compounds, their preparation and use as medicament |
| 05/02/2002 | EP1200443A1 Aromatic esters of camptothecins and methods to treat cancers |
| 05/02/2002 | EP1200442A1 2,3-benzodiazepine derivatives |
| 05/02/2002 | EP1200440A1 Quinuclidine derivatives for treatment of neurological disorders |
| 05/02/2002 | EP1200439A1 1,2-dihydro-1-oxo-parazino(1,2-a) indole derivatives |
| 05/02/2002 | EP1200438A2 Method for making debromohymenialdisine and analogs thereof |
| 05/02/2002 | EP1200435A1 Purine derivatives inhibitors of tyrosine protein kinase syk |
| 05/02/2002 | EP1200434A1 NEW CYTOTOXIC PYRIDO 2,3,4-kl]ACRIDINE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE |
| 05/02/2002 | EP1200433A1 C-6 RING-SUBSTITUTED PYRIDO 1,2- i a /i ]BENZIMIDAZOLE DERIVATIVES USEFUL IN TREATING CENTRAL NERVOUS SYSTEM DISORDERS |
| 05/02/2002 | EP1200432A1 Amido spiropiperidines promote the release of growth hormone |
| 05/02/2002 | EP1200431A2 Quinuclidine derivatives and their use as muscarinic m3 receptor ligands |
| 05/02/2002 | EP1200430A1 Thiourea and isothiourea derivatives for inhibiting ras-transformed cell growth |
| 05/02/2002 | EP1200427A2 Small molecule modulators of g protein-coupled receptor six (gpr6) |
| 05/02/2002 | EP1200424A1 C7 heterosubstituted acetate taxanes as antitumor agents |
| 05/02/2002 | EP1200422A2 Pyrazole compositions useful as inhibitors of erk |
| 05/02/2002 | EP1200419A1 Aminothiazole derivatives and their use as crf receptor ligands |
| 05/02/2002 | EP1200416A1 Oxazolidinones and their use as antiinfectives |
| 05/02/2002 | EP1200415A1 Diamino-1,2,4-triazole-carboxylic acid derivatives as gsk-3 inhibitors |
| 05/02/2002 | EP1200412A2 Imidazole antiproliferative agents |
| 05/02/2002 | EP1200410A1 Isoquinoline derivatives, pharmaceutical compositions containing the same, and a process for the preparation of the active substance |
| 05/02/2002 | EP1200409A2 Substituted isoquinoline derivatives and their use as anticonvulsants |
| 05/02/2002 | EP1200406A1 Cyclic amides and imides having selective antagonist activity at alpha-1d adrenergic receptor |
| 05/02/2002 | EP1200405A1 Benzenamine derivatives as anti-coagulants |
| 05/02/2002 | EP1200402A1 Substituted 1,5-dihydropyrrol-2-on derivatives as nmda receptor antagonists for the treatment of pain |
| 05/02/2002 | EP1200400A1 Substituted pyrrolidin-2,3,4-trion-3-oxime derivatives useful as nmda-receptor antagonists |
| 05/02/2002 | EP1200399A1 Vitamin d3 analogs |
| 05/02/2002 | EP1200398A1 3-arylsulfonyl-2-(substituted methyl)propanoic acid derivates as matrix metalloproteinase inhibitors |
| 05/02/2002 | EP1200396A1 Naphthylsulfonic acids and related compounds as glucose uptake agonists |
| 05/02/2002 | EP1200395A1 Urea derivatives as inhibitors of ccr-3 receptor |
| 05/02/2002 | EP1200393A1 Oxime amides and hydrazone amides having fungicidal activity |
| 05/02/2002 | EP1200385A1 Crystals of the sodium salt of pravastatin |
| 05/02/2002 | EP1200321A1 Valve with a valve stem wiper |
| 05/02/2002 | EP1200320A1 Valve with a two-component seal |
| 05/02/2002 | EP1200317A1 A device for spray dispensing a composition for topical application comprising vitamin e and essential fatty acids |
| 05/02/2002 | EP1200151A1 Drug delivery device for insertion into the vagina, rectum or nasal cavity |
| 05/02/2002 | EP1200133A1 Manipulation of tissue or organ type using the notch pathway |
| 05/02/2002 | EP1200130A2 Methods for treating therapy-resistant tumors |
| 05/02/2002 | EP1200129A1 Taste masking of oral quinolone liquid preparations using ion exchange resins |
| 05/02/2002 | EP1200127A2 Solutions and methods for inhibition of pain, inflammation and cartilage degradation |
| 05/02/2002 | EP1200126A1 Use of cd28 specific monoclonal antibodies for producing a pharmaceutical composition for treating virus infections |
| 05/02/2002 | EP1200125A1 Psca: prostate stem cell antigen and uses thereof |
| 05/02/2002 | EP1200114A2 Ppar delta inhibitors for the treatment of cardiovascular diseases |
| 05/02/2002 | EP1200110A1 In vivo induction for enhanced function of isolated hepatocytes |
| 05/02/2002 | EP1200108A1 Use of ginkgo extract |
| 05/02/2002 | EP1200106A1 Composition containing extracts of butyrospermum parkii and the use as medicament or dietary supplement |
| 05/02/2002 | EP1200102A1 Methods for treating autoimmune diseases |
| 05/02/2002 | EP1200101A1 Methods for transdifferentiation of body tissues |
| 05/02/2002 | EP1200100A1 Use of rhamnolipids in wound healing, treatment and prevention of gum disease and periodontal regeneration |
| 05/02/2002 | EP1200099A1 Synergistic composition comprising daunorubicin derivatives and antimetabolite compounds |
| 05/02/2002 | EP1200098A2 Combined preparations comprising daunorubicin derivatives and anti her2 antibodies |
| 05/02/2002 | EP1200097A2 Method for controlling the fidelity and the execution of reverse transcriptase by incorporating and polymerising nucleotide analogues accepted as substrates of the reverse transcription response without blocking its elongation |
| 05/02/2002 | EP1200096A1 Tixocortol pivalate suspension, mouth-wash based thereon and packaging containing same |
| 05/02/2002 | EP1200095A1 Medicament with a protective effect against oxidative-toxic substances, particularly against cardiotoxic substances |
| 05/02/2002 | EP1200094A1 Ophthalmic compositions containing antibiotics and nsaids |
| 05/02/2002 | EP1200093A2 Use of 2-amino-4-(4-fluoronaphth-1-yl)-6-isopropylpyrimidine in the treatment of gi disorders |
| 05/02/2002 | EP1200092A2 Beta-carboline drug products |
| 05/02/2002 | EP1200091A1 Beta-carboline pharmaceutical compositions |
| 05/02/2002 | EP1200090A1 Beta-carboline pharmaceutical compositions |
| 05/02/2002 | EP1200089A1 Pyridomorphinans and use thereof |
| 05/02/2002 | EP1200088A2 Paracetamol and drotaverine containing composition |
| 05/02/2002 | EP1200086A2 Methods for treating or preventing pain and anxiety |
| 05/02/2002 | EP1200085A1 Pharmaceutical and nutritional compositions containing essential fatty acids and homocysteine-lowering agents |
| 05/02/2002 | EP1200084A1 Use of an angiotensin ii type 1 receptor antagonist in the manufacture of a medicament for the treatment of cardiovascular complications |
| 05/02/2002 | EP1200083A1 Antibiotic compound |
| 05/02/2002 | EP1200082A1 Preparations for reducing oxygen consumption during physical efforts |